Factors affecting impairment of blood rheology in obese subjects

Journal of Cardiology

Volumn 60, Issue 5, 2012, Pages 401-406

  Hitsumoto, Takashi ^a  

^a Hitsumoto Medical Clinic   (Japan)

Author keywords

Blood rheology; Inflammation; Lifestyle; Micro channel array flow analyzer; Obesity; Oxidative stress

Indexed keywords

C REACTIVE PROTEIN; REACTIVE OXYGEN METABOLITE;

ADULT; ANALYZER; ARTICLE; BLOOD RHEOLOGY; BODY MASS; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DISEASE MARKER; DISEASE SEVERITY; EXERCISE; FEMALE; HUMAN; INFLAMMATION; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; MICRO CHANNEL ARRAY FLOW ANALYZER; OBESITY; OXIDATIVE STRESS; SMOKING; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE;

ADIPOSITY; BLOOD FLOW VELOCITY; BLOOD PRESSURE; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INFLAMMATION; LIFE STYLE; MALE; MIDDLE AGED; OBESITY; OXIDATIVE STRESS; RHEOLOGY; SYSTOLE;

EID: 84868612149     PISSN: 09145087     EISSN: 18764738     Source Type: Journal    
DOI: 10.1016/j.jjcc.2012.06.012     Document Type: Article

References (29)

1. Seplowitz A.H., Chien S., Smith F.R. Effects of lipoproteins on plasma viscosity. Atherosclerosis 1981, 38:89-95.
2. Letcher R.L., Chien S., Pickering T.G., Laragh J.H. Elevated blood viscosity in patients with borderline essential hypertension. Hypertension 1983, 5:757-762.
3. Tzoulaki I., Murray G.D., Lee A.J., Rumley A., Lowe G.D., Fowkes F.G. Relative value of inflammatory, hemostatic, and rheological factors for incident myocardial infarction and stroke: the Edinburgh Artery Study. Circulation 2007, 115:2119-2127.
4. Matsuo K., Ueda Y., Nishio M., Hirata A., Asai M., Nemoto T., Kashiwase K., Kodama K. Thrombogenic potential of whole blood is higher in patients with acute coronary syndrome than in patients with stable coronary diseases. Thromb Res 2011, 128:268-273.
5. Kikuchi Y., Sato K., Mizuguchi Y. Modified cell flow microchannels in a single-crystal silicon substrate and flow behavior of blood cells. Microvasc Res 1994, 47:126-139.
6. Kurihara T., Deguchi S., Kato J., Furakawa M., Tsuchiya M., Akimoto M., Ishiguro H., Hashimoto H., Niimi A., Maeda A., Shigemoto M., Yamashita K., Kawakami A., Umemura K., Nakashima M., et al. Impaired blood rheology by remnant-like lipoprotein particles: studies in patients with fatty liver disease. Clin Hemorheol Microcirc 2001, 24:217-225.
7. Seki K., Sumino H., Murakami M. Study on blood rheology measured by MC-FAN. Rinsho Byori 2003, 51:770-775. [in Japanese].
8. Seki K., Sumino H., Nara M., Ishiyama N., Nishino M., Murakami M. Relationships between blood rheology and age, body mass index, blood cell count, fibrinogen, and lipids in healthy subjects. Clin Hemorheol Microcirc 2006, 34:401-410.
9. Kotani K., Inata A., Araga S. Hemorheology by microchannel method in males with metabolic syndrome. Arch Med Res 2007, 38:463-464.
10. Fridewald W.T., Levy R.I., Fredrickson D.S. Estimation of the concentration of low density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972, 18:499-502.
11. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28:412-419.
12. Cearone M.R., Belcaro G., Caratelli M., Cornelli U., DeSanctis M.T., Incandela L., Barsotti A., Terranova R., Nicolaides A. A simple test to monitor oxidative stress. Int Angiol 1999, 18:127-130.
13. Satoh N., Kotani K., Wada H., Himeno A., Shimada S., Sasaki Y., Yamada K., Shimatsu A., Hasegawa K. Unfavorable blood rheology is closely associated with arterial stiffness in obese patients. Endocr J 2009, 56:915-918.
14. Wheatcroft S.B., Williams I.L., Shah A.M., Kearney M.T. Pathophysiological implications of insulin resistance on vascular endothelial function. Diabet Med 2003, 20:255-268.
15. Howard G., O'Leary D.H., Zaccaro D., Haffner S., Rewers M., Hamman R., Selby J.V., Saad M.F., Savage P., Bergman R. Insulin sensitivity and atherosclerosis. The insulin resistance atherosclerosis study (IRAS) investigators. Circulation 1996, 93:1809-1817.
16. Kashiwagi A., Shinozaki K., Nishio Y., Okamura T., Toda N., Kikkawa R. Free radical production in endothelial cells as a pathogenetic factor for vascular dysfunction in the insulin resistance state. Diabetes Res Clin Pract 1999, 45:199-203.
17. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 1999, 340:115-126.
18. Libby P., Ridker P.M., Maseri A. Inflammation and atherosclerosis. Circulation 2002, 105:1135-1143.
19. Kondo T., Hirose M., Kageyama K. Roles of oxidative stress and redox regulation in atherosclerosis. J Atheroscler Thromb 2009, 16:532-538.
20. Hong Y.J., Jeong M.H., Choi Y.H., Ma E.H., Ko J.S., Lee M.G., Park K.H., Sim D.S., Yoon N.S., Youn H.J., Kim K.H., Park H.W., Kim J.H., Ahn Y., Cho J.G., et al. Age-related differences in virtual histology-intravascular ultrasound findings in patients with coronary artery disease. J Cardiol 2010, 55:224-231.
21. Soeki T., Niki T., Kusunose K., Bando S., Hirata Y., Tomita N., Yamaguchi K., Koshiba K., Yagi S., Taketani Y., Iwase T., Yamada H., Wakatsuki T., Akaike M., Sata M. Elevated concentrations of pentraxin 3 are associated with coronary plaque vulnerability. J Cardiol 2011, 58:151-157.
22. Tzoulaki I., Murray G.D., Lee A.J., Rumley A., Lowe G.D., Fowkes F.G. Inflammatory, haemostatic, and rheological markers for incident peripheral arterial disease: Edinburgh Artery Study. Eur Heart J 2007, 28:354-362.
23. Podrez E.A., Byzova T.V., Febbraio M., Salomon R.G., Ma Y., Valiyaveettil M., Poliakov E., Sun M., Finton P.J., Curtis B.R., Chen J., Zhang R., Silverstein R.L., Hazen S.L. Platelet CD36 links hyperlipidemia, oxidant stress and a prothrombotic phenotype. Nat Med 2007, 13:1086-1095.
24. Kinlay S., Schwartz G.G., Olsson A.G., Rifai N., Leslie S.J., Sasiela W.J., Szarek M., Libby P., Ganz P. Myocardial ischemia reduction with aggressive cholesterol lowering study investigators: high-dose atorvastatin enhances the decline in inflammatory markers in patients with acute coronary syndromes in the MIRACL study. Circulation 2003, 108:1560-1566.
25. Hirooka Y., Kimura Y., Sagara Y., Ito K., Sunagawa K. Effects of valsartan or amlodipine on endothelial function and oxidative stress after one year follow-up in patients with essential hypertension. Clin Exp Hypertens 2008, 3:267-276.
26. Waters D.D. Exploring new indications for statins beyond atherosclerosis: successes and setbacks. J Cardiol 2010, 55:155-162.
27. Shimada S., Hasegawa K., Wada H., Terashima S., Satoh-Asahara N., Yamakage H., Kitaoka S., Akao M., Shimatsu A., Takahashi Y. High blood viscosity is closely associated with cigarette smoking and markedly reduced by smoking cessation. Circ J 2011, 75:185-189.
28. Adachi H., Sakurai S., Tanehata M., Oshima S., Taniguchi K. Effect of long-term exercise training on blood viscosity during endurance exercise at an anaerobic threshold intensity. Jpn Circ J 2000, 64:848-850.
29. Coppola L., Grassia A., Coppola A., Tondi G., Peluso G., Mordente S., Gombos G. Effects of a moderate-intensity aerobic program on blood viscosity, platelet aggregation and fibrinolytic balance in young and middle-aged sedentary subjects. Blood Coagul Fibrinolysis 2004, 15:31-37.